Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-08-20 Sale | 2024-08-22 6:00 pm | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 4,181 | $1.2291 | $5,139 | 130,797 (Direct) | View |
2024-03-19 Sale | 2024-03-21 4:41 pm | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 5,268 | $2.0855 | $10,986 | 117,728 (Direct) | View |
2023-12-20 Sale | 2023-12-22 4:11 pm | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 4,077 | $1.3807 | $5,629 | 97,996 (Direct) | View |
2023-09-22 Sale | 2023-09-22 7:12 pm | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 5,486 | $1.3006 | $7,135 | 80,609 (Direct) | View |
2023-03-16 Sale | 2023-03-20 6:43 pm | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 2,037 | $1.979 | $4,031 | 71,095 (Direct) | View |
2022-07-20 Sale | 2022-07-21 4:10 pm | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 5,602 | $1.4223 | $7,968 | 43,689 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-08-20 Exercise | 2024-08-22 6:00 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 11,250 | $0 | 130,797 (Direct) | View |
2024-01-18 Option Award | 2024-01-19 8:43 pm | N/A 2034-01-17 | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 200,000 | $0 | 297,996 (Direct) | View |
2023-12-17 Exercise | 2023-12-19 7:55 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 11,250 | $0 | 113,323 (Direct) | View |
2023-09-20 Option Award | 2023-09-22 7:12 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 15,000 | $0 | 80,609 (Direct) | View |
2023-02-02 Option Award | 2023-02-06 4:48 pm | N/A 2033-02-01 | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 175,000 | $0 | 223,132 (Direct) | View |
2022-08-10 Option Award | 2022-08-12 4:58 pm | N/A 2032-08-09 | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 157,500 | $0 | 157,500 (Direct) | View |
2022-07-19 Option Award | 2022-07-21 4:10 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 15,000 | $0 | 43,689 (Direct) | View |
2022-02-02 Option Award | 2022-02-04 4:52 pm | N/A 2032-02-01 | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 157,500 | $0 | 169,291 (Direct) | View |
2021-10-24 Option Award | 2021-10-26 4:29 pm | N/A 2031-10-23 | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 70,000 | $0 | 70,000 (Direct) | View |
2021-02-26 Option Award | 2021-03-02 4:59 pm | N/A 2031-02-25 | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 125,000 | $0 | 125,000 (Direct) | View |
2020-02-14 Option Award | 2020-02-19 6:39 pm | N/A 2030-02-13 | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 100,000 | $0 | 100,000 (Direct) | View |